Plant-Based Anticancer Compounds With a Focus on Breast Cancer.
adverse events
anticancer therapeutic
breast cancer
carcinogenesis
plant‐based compounds
Journal
Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728
Informations de publication
Date de publication:
Oct 2024
Oct 2024
Historique:
revised:
11
07
2024
received:
18
10
2023
accepted:
11
08
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
ppublish
Résumé
Breast cancer is a common form of cancer among women characterized by the growth of malignant cells in the breast tissue. The most common treatments for this condition include chemotherapy, surgical intervention, radiation therapy, hormone therapy, and biological therapy. The primary issues associated with chemotherapy and radiation therapy are their adverse events and significant financial burden among patients in underdeveloped countries. This highlights the need to explore and develop superior therapeutic options that are less detrimental and more economically efficient. Plants provide an abundant supply of innovative compounds and present a promising new avenue for investigating cancer. Plants and their derivations are undergoing a revolution due to their reduced toxicity, expediency, cost-effectiveness, safety, and simplicity in comparison to conventional treatment methods. Natural products are considered promising candidates for the development of anticancer drugs, due perhaps to the diverse pleiotropic effects on target events. The effects of plant-derived products are limited to cancer cells while leaving healthy cells unaffected. Identification of compounds with strong anticancer properties and development of plant-based medications for cancer treatment might be crucial steps in breast cancer therapy. Although bioactive compounds have potent anticancer properties, they also have drawbacks that need to be resolved before their application in clinical trials and improved for the approved drugs. This study aims to give comprehensive information on known anticancer compounds, including their sources and molecular mechanisms of actions, along with opportunities and challenges in plant-based anticancer therapies.
Substances chimiques
Antineoplastic Agents, Phytogenic
0
Biological Products
0
Plant Extracts
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e70012Informations de copyright
© 2024 The Author(s). Cancer Reports published by Wiley Periodicals LLC.
Références
P. Mathur, K. Sathishkumar, M. Chaturvedi, et al., “Cancer Statistics, 2020: Report From National Cancer Registry Programme, India,” JCO Global Oncology 6 (2020): 1063–1075.
P. Nenclares and K. Harrington, “The Biology of Cancer,” Medicine 48, no. 2 (2020): 67–72.
R. ArefNezhad, F. Rezaei‐Tazangi, H. Roghani‐Shahraki, et al., “Human Umbilical Cord Mesenchymal Stem Cells: Heralding an Effective Treatment Against Esophageal Cancer?” Cell Biology International 47, no. 4 (2023): 714–719.
E. N. Kontomanolis, A. Koutras, A. Syllaios, et al., “Role of Oncogenes and Tumor‐Suppressor Genes in Carcinogenesis: A Review,” Anticancer Research 40, no. 11 (2020): 6009–6015.
G. M. Cragg, and D. J. Newman, “Natural Products: a Continuing Source of Novel Drug Leads,” Biochimica et Biophysica Acta 1830, no. 6 (2013): 3670–3695.
S. Wu, W. Zhu, P. Thompson, and Y. A. Hannun, “Evaluating Intrinsic and Non‐Intrinsic Cancer Risk Factors,” Nature Communications 9, no. 1 (2018): 1–12.
A. M. Hasan‐Abad, E. Adabi, E. Sadroddiny, et al., “Functional Deimmunization of Interferon Beta‐1b by Identifying and Silencing Human T Cells Epitopes,” Iranian Journal of Allergy, Asthma, and Immunology 18 (2019): 427–440.
I. V. Mavragani, Z. Nikitaki, S. A. Kalospyros, and A. G. Georgakilas, “Ionizing Radiation and Complex DNA Damage: From Prediction to Detection Challenges and Biological Significance,” Cancers 11, no. 11 (2019): 1789.
F. Rezaei‐Tazangi, H. Roghani‐Shahraki, M. Khorsand Ghaffari, et al., “The Therapeutic Potential of Common Herbal and Nano‐Based Herbal Formulations Against Ovarian Cancer: New Insight into the Current Evidence,” Pharmaceuticals 14, no. 12 (2021): 1315.
M. M. Azevedo, C. Pina‐Vaz, and F. Baltazar, “Microbes and Cancer: Friends or Faux?” International Journal of Molecular Sciences 21, no. 9 (2020): 3115.
M. Sisakht, A. Mahmoodzadeh, M. Zahedi, D. Rostamzadeh, A. M. Hasan‐Abad, and A. Atapour, “In Silico Approach for Designing a Novel Recombinant Fusion Protein as a Candidate Vaccine Against HPV,” Current Proteomics 18, no. 4 (2021): 549–562.
H. Zhao, L. Wu, G. Yan, et al., “Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention,” Signal Transduction and Targeted Therapy 6, no. 1 (2021): 1–46.
M. Kay, A. M. Hasan‐Abad, Z. Hojati, and H. Korbekandi, “Targeted Mutations in Val101 and Arg27 Interferon Beta Protein Increase Its Transcriptional and Translational Activities,” Cytokine 78 (2016): 1–6.
I. M. Abdel‐Salam, A. Abou‐Bakr, and M. Ashour, “Cytotoxic Effect of Aqueous Ethanolic Extract of Luffa Cylindrica Leaves on Cancer Stem Cells CD44+/24‐in Breast Cancer Patients With Various Molecular Sub‐Types Using Tissue Samples In Vitro,” Journal of Ethnopharmacology 238 (2019): 111877.
Y. S. B. Baraya, K. K. Wong, and N. S. Yaacob, “The Immunomodulatory Potential of Selected Bioactive Plant‐Based Compounds in Breast Cancer: A Review,” Anti‐Cancer Agents in Medicinal Chemistry 17, no. 6 (2017): 770–783.
M. Arnold, E. Morgan, H. Rumgay, et al., “Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040,” Breast 66 (2022): 15–23.
H. Chen, J. Yang, Y. Yang, J. Zhang, Y. Xu, and X. Lu, “The Natural Products and Extracts: Anti‐Triple‐Negative Breast Cancer In Vitro,” Chemistry & Biodiversity 18, no. 7 (2021): e2001047.
V. Chowjarean and K. Sadabpod, “Antiproliferative Effect of Grammatophyllum Speciosum Ethanolic Extract and Its Bioactive Compound on Human Breast Cancer Cells,” Scientific World Journal 2021 (2021): 1–9.
D. K. Chellappan, J. Chellian, Z. Y. Ng, et al., “The Role of Pazopanib on Tumour Angiogenesis and in the Management of Cancers: A Review,” Biomedicine and Pharmacotherapy 96 (2017): 768–781.
N. Kasiri, M. Rahmati, L. Ahmadi, N. Eskandari, and H. Motedayyen, “Therapeutic Potential of Quercetin on Human Breast Cancer in Different Dimensions,” Inflammopharmacology 28 (2020): 39–62.
C. Churiyah, S. Ningsih, and F. Firdayani, “The Cytotoxic, Apoptotic Induction, and Cell Cycle Arrest Activities of Solanum nigrum L. Ethanolic Extract on MCF‐7 Human Breast Cancer Cell,” Asian Pacific Journal of Cancer Prevention 21(12):3735 (2020): 3735–3741.
V. Keyvani, E. Riahi, M. Yousefi, et al., “Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies,” Frontiers in Pharmacology 13 (2022): 823572.
K. S. Alharbi, M. A. J. Shaikh, W. H. Almalki, et al., “PI3K/Akt/mTOR Pathways Inhibitors With Potential Prospects in Non‐Small‐Cell Lung Cancer,” Journal of Environmental Pathology, Toxicology, and Oncology 41, no. 4 (2022): 85–102.
V. Colamba Pathiranage, J. N. Lowe, U. Rajagopalan, et al., “Hexane Extract of Garcinia Quaesita Fruits Induces Apoptosis in Breast Cancer Stem Cells Isolated From Triple Negative Breast Cancer Cell Line MDA‐MB‐231,” Nutrition and Cancer 73, no. 5 (2021): 845–855.
T. B. Emran, A. Shahriar, A. R. Mahmud, et al., “Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches,” Frontiers Oncology 12 (2022): 891652.
M. Collard, P. E. Gallagher, and E. A. Tallant, “A Polyphenol‐Rich Extract From Muscadine Grapes Inhibits Triple‐Negative Breast Tumor Growth,” Integrative Cancer Therapies 19 (2020): 1534735420917444.
G. Gupta, W. H. Al‐Malki, I. Kazmi, et al., “The Role of HGF/MET in Liver Cancer,” Future Medicinal Chemistry 13, no. 21 (2021): 1829–1832.
P. R. Dandawate, D. Subramaniam, R. A. Jensen, and S. Anant, “Targeting Cancer Stem Cells and Signaling Pathways by Phytochemicals: Novel Approach for Breast Cancer Therapy,” Seminars in Cancer Biology 40–41 (2016): 192–208.
R. Dhouibi, H. Affes, M. B. Salem, et al., “Screening of Pharmacological Uses of Urtica dioica and Others Benefits,” Progress in Biophysics and Molecular Biology 150 (2020): 67–77.
D. A. Espinosa‐Paredes, J. Cornejo‐Garrido, M. A. Moreno‐Eutimio, O. P. Martínez‐Rodríguez, M. E. Jaramillo‐Flores, and C. Ordaz‐Pichardo, “Echinacea angustifolia DC Extract Induces Apoptosis and Cell Cycle Arrest and Synergizes With Paclitaxel in the MDA‐MB‐231 and MCF‐7 Human Breast Cancer Cell Lines,” Nutrition and Cancer 73, no. 11–12 (2021): 2287–2305.
B. P. George, R. Chandran, S. Thamburaj, and T. Parimelazhagan, “Combined Effect of Vaccinium Nilgiriensis Bark Extract and 680 nm Laser Irradiation in Inducing Breast Cancer Cell Death,” Anti‐Cancer Agents in Medicinal Chemistry 21, no. 2 (2021): 207–213.
P. Graidist, M. Martla, and Y. Sukpondma, “Cytotoxic Activity of Piper cubeba Extract in Breast Cancer Cell Lines,” Nutrients 7, no. 4 (2015): 2707–2718.
A. R. Guerra, B. I. Soares, C. S. Freire, A. J. Silvestre, M. F. Duarte, and I. F. Duarte, “Metabolic Effects of a Eucalyptus Bark Lipophilic Extract on Triple Negative Breast Cancer and Nontumor Breast Epithelial Cells,” Journal of Proteome Research 20, no. 1 (2020): 565–575.
I. M. Tahir, A. Rauf, H. Mehboob, et al., “Prognostic Significance of Programmed Death‐1 and Programmed Death Ligand‐1 Proteins in Breast Cancer,” Human Antibodies 30, no. 3 (2022): 131–150.
M. J. A. Cordero, N. M. Villar, M. N. Sánchez, M. L. Pimentel‐Ramírez, A. García‐Rillo, and E. G. Valverde, “Breast Cancer and Body Image as a Prognostic Factor of Depression: A Case Study in México City,” Nutrición Hospitalaria 31, no. 1 (2015): 371–379.
M. R. Islam, F. Islam, M. H. Nafady, et al., “Natural Small Molecules in Breast Cancer Treatment: Understandings From a Therapeutic Viewpoint,” Molecules 27, no. 7 (2022): 2165.
D. Miricescu, A. Totan, I.‐I. Stanescu‐Spinu, S. C. Badoiu, C. Stefani, and M. Greabu, “PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects,” International Journal of Molecular Sciences 22, no. 1 (2020): 173.
J.‐L. Deng, Y.‐h. Xu, and G. Wang, “Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis,” Frontiers in Genetics 10 (2019): 695.
J. Howard, C. Y. Goh, K. W. Gorzel, M. Higgins, and A. McCann, “The Potential Role of Cofilin‐1 in Promoting Triple Negative Breast Cancer (TNBC) Metastasis via the Extracellular Vesicles (EVs),” Translational Oncology 15, no. 1 (2022): 101247.
L. Yin, J.‐J. Duan, X.‐W. Bian, and S.‐c. Yu, “Triple‐Negative Breast Cancer Molecular Subtyping and Treatment Progress,” Breast Cancer Research 22 (2020): 1–13.
M. Zakikhani, M.‐J. Blouin, E. Piura, and M. N. Pollak, “Metformin and Rapamycin Have Distinct Effects on the AKT Pathway and Proliferation in Breast Cancer Cells,” Breast Cancer Research and Treatment 123 (2010): 271–279.
W. Wang, R. Eddy, and J. Condeelis, “The Cofilin Pathway in Breast Cancer Invasion and Metastasis,” Nature Reviews Cancer 7, no. 6 (2007): 429–440.
M. Souzaki, M. Kubo, M. Kai, et al., “Hedgehog Signaling Pathway Mediates the Progression of Non‐Invasive Breast Cancer to Invasive Breast Cancer,” Cancer Science 102, no. 2 (2011): 373–381.
J. Cidado and B. H. Park, “Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy,” Journal of Mammary Gland Biology and Neoplasia 17 (2012): 205–216.
J. Pascual and N. Turner, “Targeting the PI3‐Kinase Pathway in Triple‐Negative Breast Cancer,” Annals of Oncology 30, no. 7 (2019): 1051–1060.
S. Vinogradov and X. Wei, “Cancer Stem Cells and Drug Resistance: The Potential of Nanomedicine,” Nanomedicine 7, no. 4 (2012): 597–615.
C. R. Patra, S. Mukherjee, and R. Kotcherlakota, “Biosynthesized Silver Nanoparticles: A Step Forward for Cancer Theranostics?” Nanomedicine 9, no. 10 (2014): 1445–1448.
S. Mukherjee and C. R. Patra, “Therapeutic Application of Anti‐Angiogenic Nanomaterials in Cancers,” Nanoscale 8, no. 25 (2016): 12444–12470.
M. Mohammadi, A. Moradi Hasan‐Abad, P. Dehghani, et al., “Dicentracin‐Like From Asian Sea Bass Fish and Moronecidine‐Like From Hippocampus comes: Two Candidate Antimicrobial Peptides Against Leishmanina Major Infection,” International Journal of Peptide Research and Therapeutics 27 (2021): 769–778.
M. Caruso, A. Colombo, L. Fedeli, et al., “Isolation of Endophytic Fungi and Actinomycetes Taxane Producers,” Annals of Microbiology 50, no. 1 (2000): 3–14.
B. A. Weaver, “How Taxol/Paclitaxel Kills Cancer Cells,” Molecular Biology of the Cell 25, no. 18 (2014): 2677–2681.
A. M. Hasan‐Abad, M. Mohammadi, H. Mirzaei, M. Mehrabi, H. Motedayyen, and R. Arefnezhad, “Impact of Oligomerization on the Allergenicity of Allergens,” Clinical and Molecular Allergy 20, no. 1 (2022): 1–10.
T. N. Aung, Z. Qu, R. D. Kortschak, and D. L. Adelson, “Understanding the Effectiveness of Natural Compound Mixtures in Cancer Through Their Molecular Mode of Action,” International Journal of Molecular Sciences 18, no. 3 (2017): 656.
S. Singh, B. Sharma, S. S. Kanwar, and A. Kumar, “Lead Phytochemicals for Anticancer Drug Development,” Frontiers in Plant Science 7 (2016): 1667.
D. J. Newman and G. M. Cragg, “Natural Products as Sources of New Drugs Over the Nearly Four Decades From 01/1981 to 09/2019,” Journal of Natural Products 83, no. 3 (2020): 770–803.
H. Yuan, Q. Ma, L. Ye, and G. Piao, “The Traditional Medicine and Modern Medicine From Natural Products,” Molecules 21, no. 5 (2016): 559.
G. M. Cragg and J. M. Pezzuto, “Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents,” Medical Principles and Practice 25, no. S2 (2016): S41–S59.
A. M. Seca and D. C. Pinto, “Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application,” International Journal of Molecular Sciences 19, no. 1 (2018): 263.
A. Tariq, S. Sadia, K. Pan, et al., “A Systematic Review on Ethnomedicines of Anti‐Cancer Plants,” Phytotherapy Research 31, no. 2 (2017): 202–264.
P. Thakore, R. K. Mani, and S. J. Kavitha, “A Brief Review of Plants Having Anti‐Cancer Property,” International Journal of Pharmaceutical Research and Development 3 (2012): 129–136.
J. Liu, S. Wang, S. Tian, et al., “Nobiletin Inhibits Breast Cancer via p38 Mitogen‐Activated Protein Kinase, Nuclear Transcription Factor‐κB, and Nuclear Factor Erythroid 2‐Related Factor 2 Pathways in MCF‐7 Cells,” Food & Nutrition Research 62 (2018): 62.
G. G.‐L. Yue, S. Xie, J. K.‐M. Lee, et al., “New Potential Beneficial Effects of Actein, a Triterpene Glycoside Isolated From Cimicifuga Species, in Breast Cancer Treatment,” Scientific Reports 6, no. 1 (2016): 35263.
Y. Kong, F. Li, Y. Nian, et al., “KHF16 Is a Leading Structure From Cimicifuga foetida That Suppresses Breast Cancer Partially by Inhibiting the NF‐κB Signaling Pathway,” Theranostics 6, no. 6 (2016): 875–886.
H. El Hasasna, A. Saleh, H. A. Samri, et al., “Rhus coriaria Suppresses Angiogenesis, Metastasis and Tumor Growth of Breast Cancer Through Inhibition of STAT3, NFκB and Nitric Oxide Pathways,” Scientific Reports 6, no. 1 (2016): 21144.
X. Zhao, W. Zhang, J. Fan, X. Chen, and X. Wang, “Application of Mesenchymal Stem Cell Exosomes in the Treatment of Skin Wounds,” Smart Materials in Medicine 4 (2023): 578–589.
J. Feng, Q. Xiu, Y. Huang, Z. Troyer, B. Li, and L. Zheng, “Plant‐Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and Future,” Advanced Materials 35, no. 24 (2023): 2207826.
N. P. Ly, H. S. Han, M. Kim, J. H. Park, and K. Y. Choi, “Plant‐Derived Nanovesicles: Current Understanding and Applications for Cancer Therapy,” Bioactive Materials 22 (2023): 365–383.
S. Raimondo, F. Naselli, S. Fontana, et al., “Citrus Limon‐Derived Nanovesicles Inhibit Cancer Cell Proliferation and Suppress CML Xenograft Growth by Inducing TRAIL‐Mediated Cell Death,” Oncotarget 6, no. 23 (2015): 19514–19527.
M. Cao, H. Yan, X. Han, et al., “Ginseng‐Derived Nanoparticles Alter Macrophage Polarization to Inhibit Melanoma Growth,” Journal for Immunotherapy of Cancer 7 (2019): 1–18.
M. Zhang, B. Xiao, H. Wang, et al., “Edible Ginger‐Derived Nano‐Lipids Loaded With Doxorubicin as a Novel Drug‐Delivery Approach for Colon Cancer Therapy,” Molecular Therapy 24, no. 10 (2016): 1783–1796.
S. Saroj, P. Us, S. Patil, et al., “Herb Extracellular Vesicle‐Chitosan‐PEGylated Graphene Oxide Conjugate Delivers Estrogen Receptor α Targeting siRNA to Breast Cancer Cells,” ACS Applied Bio Materials 7, no. 5 (2024): 2741–2751.
L. Cui, G. Perini, A. Augello, V. Palmieri, M. De Spirito, and M. Papi, “Plant‐Derived Extracellular Nanovesicles: A Promising Biomedical Approach for Effective Targeting of Triple Negative Breast Cancer Cells,” Frontiers in Bioengineering and Biotechnology 12 (2024): 1390708.
Z. Xu, Y. Xu, K. Zhang, et al., “Plant‐Derived Extracellular Vesicles (PDEVs) in Nanomedicine for Human Disease and Therapeutic Modalities,” Journal of Nanobiotechnology 21, no. 1 (2023): 114.
J. Zou, L. Zhu, X. Jiang, et al., “Curcumin Increases Breast Cancer Cell Sensitivity to Cisplatin by Decreasing FEN1 Expression,” Oncotarget 9, no. 13 (2018): 11268–11278.
E. Kim, Y.‐J. Kim, Z. Ji, et al., “ROR Activation by Nobiletin Enhances Antitumor Efficacy via Suppression of IκB/NF‐κB Signaling in Triple‐Negative Breast Cancer,” Cell Death and Disease 13, no. 4 (2022): 374.
S. Aghamiri, A. Jafarpour, F. Zandsalimi, M. Aghemiri, and M. Shoja, “Effect of Resveratrol on the Radiosensitivity of 5‐FU in Human Breast Cancer MCF‐7 Cells,” Journal of Cellular Biochemistry 120, no. 9 (2019): 15671–15677.
N. H. Shehatta, T. M. Okda, G. A. Omran, and M. M. Abd‐Alhaseeb, “Baicalin; a Promising Chemopreventive Agent, Enhances the Antitumor Effect of 5‐FU Against Breast Cancer and Inhibits Tumor Growth and Angiogenesis in Ehrlich Solid Tumor,” Biomedicine and Pharmacotherapy 146 (2022): 112599.
J. Iqbal, B. A. Abbasi, T. Mahmood, et al., “Plant‐Derived Anticancer Agents: A Green Anticancer Approach,” Asian Pacific Journal of Tropical Biomedicine 7, no. 12 (2017): 1129–1150.
A. S. Choudhari, P. C. Mandave, M. Deshpande, P. Ranjekar, and O. Prakash, “Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice,” Frontiers in Pharmacology 10 (2020): 1614.
A. Jafri, S. Amjad, S. Bano, S. Kumar, M. Serajuddin, and M. Arshad, “Efficacy of Nano‐Phytochemicals Over Pure Phytochemicals Against Various Cancers: Current Trends and Future Prospects,” in Nanomaterials and Environmental Biotechnology (Switzerland: Springer, 2020), 407–424.
C. D. Santos and C. J. G. Schier, “Colchicine, Podophyllin, and the Vinca Alkaloids,” Goldfrank's Toxicologic Emergencies, 11th ed. (New York: The McGraw‐Hill Companies, 2019), 501–510.
S. Noguchi, H. Atsumi, Y. Iwao, T. Kan, and S. Itai, “Nobiletin: A Citrus Flavonoid Displaying Potent Physiological Activity,” Acta Crystallographica Section C: Structural Chemistry 72, no. 2 (2016): 124–127.
H. Wu, L. Chen, F. Zhu, X. Han, L. Sun, and K. Chen, “The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells,” Toxins 11, no. 12 (2019): 731.
Y. Fu, H. Chang, X. Peng, et al., “Resveratrol Inhibits Breast Cancer Stem‐Like Cells and Induces Autophagy via Suppressing Wnt/β‐Catenin Signaling Pathway,” PLoS One 9, no. 7 (2014): e102535.
J. Suh, D.‐H. Kim, and Y.‐J. Surh, “Resveratrol Suppresses Migration, Invasion and Stemness of Human Breast Cancer Cells by Interfering With Tumor‐Stromal Cross‐Talk,” Archives of Biochemistry and Biophysics 643 (2018): 62–71.
H.‐W. Lai, S.‐Y. Chien, S.‐J. Kuo, et al., “The Potential Utility of Curcumin in the Treatment of HER‐2‐Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study With Herceptin,” Evidence‐Based Complementary and Alternative Medicine 2012 (2012): 1–12.
X.‐D. Sun, X.‐E. Liu, and D.‐S. Huang, “Curcumin Induces Apoptosis of Triple‐Negative Breast Cancer Cells by Inhibition of EGFR Expression,” Molecular Medicine Reports 6, no. 6 (2012): 1267–1270.
J.‐M. Kim, E.‐M. Noh, K.‐B. Kwon, et al., “Curcumin Suppresses the TPA‐Induced Invasion Through Inhibition of PKCα‐Dependent MMP‐Expression in MCF‐7 Human Breast Cancer Cells,” Phytomedicine 19, no. 12 (2012): 1085–1092.
M. Gallardo and G. M. Calaf, “Curcumin Inhibits Invasive Capabilities Through Epithelial Mesenchymal Transition in Breast Cancer Cell Lines,” International Journal of Oncology 49, no. 3 (2016): 1019–1027.
S. S. Islam, I. Al‐Sharif, A. Sultan, A. Al‐Mazrou, A. Remmal, and A. Aboussekhra, “Eugenol Potentiates Cisplatin Anti‐Cancer Activity Through Inhibition of ALDH‐Positive Breast Cancer Stem Cells and the NF‐κB Signaling Pathway,” Molecular Carcinogenesis 57, no. 3 (2018): 333–346.
Y. Gao, H. Liu, H. Wang, et al., “Baicalin Inhibits Breast Cancer Development via Inhibiting IĸB Kinase Activation In Vitro and In Vivo,” International Journal of Oncology 53, no. 6 (2018): 2727–2736.
C. A. Dehelean, I. Marcovici, C. Soica, et al., “Plant‐Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy,” Molecules 26, no. 4 (2021): 1109.
H.‐S. Chen, M.‐H. Bai, T. Zhang, G.‐D. Li, and M. Liu, “Ellagic Acid Induces Cell Cycle Arrest and Apoptosis Through TGF‐β/Smad3 Signaling Pathway in Human Breast Cancer MCF‐7 Cells,” International Journal of Oncology 46, no. 4 (2015): 1730–1738.
J. Kim, J. Yoo, J. Kim, et al., “Anticancer Effect of Mountain Ginseng,” Evidence‐based Complementary and Alternative Medicine 2020 (2020): 1344.
M. V. Sepporta, R. Fuccelli, P. Rosignoli, et al., “Oleuropein Inhibits Tumour Growth and Metastases Dissemination in Ovariectomised Nude Mice With MCF‐7 Human Breast Tumour Xenografts,” Journal of Functional Foods 8 (2014): 269–273.
N. A. Razak, N. Abu, W. Y. Ho, et al., “Cytotoxicity of Eupatorin in MCF‐7 and MDA‐MB‐231 Human Breast Cancer Cells via Cell Cycle Arrest, Anti‐Angiogenesis and Induction of Apoptosis,” Scientific Reports 9, no. 1 (2019): 1514.
J.‐y. Xing, G.‐p. Song, J.‐p. Deng, et al., “Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives Against Human Cancer Cells In Vitro,” PLoS One 10, no. 12 (2015): e0144781.
F. P. Chen and M. H. Chien, “Effects of Phytoestrogens on the Activity and Growth of Primary Breast Cancer Cells Ex Vivo,” Journal of Obstetrics and Gynaecology Research 45, no. 7 (2019): 1352–1362.
R. Bosviel, E. Dumollard, P. Déchelotte, Y.‐J. Bignon, and D. Bernard‐Gallon, “Can Soy Phytoestrogens Decrease DNA Methylation inBRCA1 andBRCA2 Oncosuppressor Genes in Breast Cancer?” OMICS: A Journal of Integrative Biology 16, no. 5 (2012): 235–244.
T. Efferth, H. Dunstan, A. Sauerbrey, H. Miyachi, and C. R. Chitambar, “The Anti‐Malarial Artesunate Is Also Active Against Cancer,” International Journal of Oncology 18, no. 4 (2001): 767–773.
X. Wang, Y. Yang, Y. An, and G. Fang, “The Mechanism of Anticancer Action and Potential Clinical Use of Kaempferol in the Treatment of Breast Cancer,” Biomedicine and Pharmacotherapy 117 (2019): 109086.
M. Akram, M. Iqbal, M. Daniyal, and A. U. Khan, “Awareness and Current Knowledge of Breast Cancer,” Biological Research 50 (2017): 1–23.
X. Zhang, J. Hu, and Y. Chen, “Betulinic Acid and the Pharmacological Effects of Tumor Suppression,” Molecular Medicine Reports 14, no. 5 (2016): 4489–4495.
L. Song, X. Chen, L. Mi, et al., “Icariin‐Induced Inhibition of SIRT6/NF‐κB Triggers Redox Mediated Apoptosis and Enhances Anti‐Tumor Immunity in Triple‐Negative Breast Cancer,” Cancer Science 111, no. 11 (2020): 4242–4256.
S. K. Król, M. Kiełbus, A. Rivero‐Müller, and A. Stepulak, “Comprehensive Review on Betulin as a Potent Anticancer Agent,” BioMed Research International 2015 (2015): 1–11.
N. Wang, Z. Wang, C. Peng, et al., “Dietary Compound Isoliquiritigenin Targets GRP78 to Chemosensitize Breast Cancer Stem Cells via β‐Catenin/ABCG2 Signaling,” Carcinogenesis 35, no. 11 (2014): 2544–2554.
J. Xu, Y. Long, L. Ni, et al., “Anticancer Effect of Berberine Based on Experimental Animal Models of Various Cancers: A Systematic Review and Meta‐Analysis,” BMC Cancer 19, no. 1 (2019): 1–20.
H. Babich, M. Krupka, H. A. Nissim, and H. L. Zuckerbraun, “Differential In Vitro Cytotoxicity of (−)‐Epicatechin Gallate (ECG) to Cancer and Normal Cells From the Human Oral Cavity,” Toxicology In Vitro 19, no. 2 (2005): 231–242.
H. Li, Q. Wang, L. Dong, et al., “Morusin Suppresses Breast Cancer Cell Growth In Vitro and In Vivo Through C/EBPβ and PPARγ Mediated Lipoapoptosis,” Journal of Experimental & Clinical Cancer Research 34 (2015): 1–12.
G.‐Y. Yang, J. Liao, K. Kim, E. J. Yurkow, and C. S. Yang, “Inhibition of Growth and Induction of Apoptosis in Human Cancer Cell Lines by Tea Polyphenols,” Carcinogenesis 19, no. 4 (1998): 611–616.
L. Cheng, T.‐S. Xia, Y.‐F. Wang, et al., “The Apoptotic Effect of D Rhamnose β‐Hederin, a Novel Oleanane‐Type Triterpenoid Saponin on Breast Cancer Cells,” PLoS One 9, no. 3 (2014): e90848.
Y. Ci, Y. Zhang, Y. Liu, et al., “Myricetin Suppresses Breast Cancer Metastasis Through Down‐Regulating the Activity of Matrix Metalloproteinase (MMP)‐2/9,” Phytotherapy Research 32, no. 7 (2018): 1373–1381.
V. A. Silva, M. N. Rosa, O. Martinho, et al., “Modified Ingenol Semi‐Synthetic Derivatives From Euphorbia Tirucalli Induce Cytotoxicity on a Large Panel of Human Cancer Cell Lines,” Investigational New Drugs 37 (2019): 1029–1035.
Y. Pan, W. Wang, S. Huang, et al., “Beta‐Elemene Inhibits Breast Cancer Metastasis Through Blocking Pyruvate Kinase M2 Dimerization and Nuclear Translocation,” Journal of Cellular and Molecular Medicine 23, no. 10 (2019): 6846–6858.
Y. Huang, H. Huang, S. Wang, F. Chen, and G. Zheng, “Dehydrocorydaline Inhibits the Tumorigenesis of Breast Cancer MDA‐MB‐231 Cells,” Molecular Medicine Reports 22, no. 1 (2020): 43–50.
J. H. Ko, M. H. Yang, S. H. Baek, D. Nam, S. H. Jung, and K. S. Ahn, “Theacrine Attenuates Epithelial Mesenchymal Transition in Human Breast Cancer MDA‐MB‐231 Cells,” Phytotherapy Research 33, no. 7 (2019): 1934–1942.
M. Li, B. Li, Z.‐M. Xia, et al., “Anticancer Effects of Five Biflavonoids From Ginkgo biloba L Male Flowers In Vitro,” Molecules 24, no. 8 (2019): 1496.
Y. Ding, J. He, J. Huang, et al., “Harmine Induces Anticancer Activity in Breast Cancer Cells via Targeting TAZ,” International Journal of Oncology 54, no. 6 (2019): 1995–2004.
A. Bommareddy, K. Knapp, A. Nemeth, et al., “Alpha‐Santalol, a Component of Sandalwood Oil Inhibits Migration of Breast Cancer Cells by Targeting the β‐Catenin Pathway,” Anticancer Research 38, no. 8 (2018): 4475–4480.
J. Peng, G. Fan, and Y. Wu, “Preparative Isolation of Four New and Two Known Flavonoids From the Leaf of Patrinia villosa Juss. By Counter‐Current Chromatography and Evaluation of Their Anticancer Activities In Vitro,” Journal of Chromatography A 1115, no. 1–2 (2006): 103–111.
S. Hu, W. Zheng, and L. Jin, “Astragaloside IV Inhibits Cell Proliferation and Metastasis of Breast Cancer via Promoting the Long Noncoding RNA TRHDE‐AS1,” Journal of Natural Medicines 75 (2021): 156–166.
D. Choudhury, A. Ganguli, D. G. Dastidar, B. R. Acharya, A. Das, and G. Chakrabarti, “Apigenin Shows Synergistic Anticancer Activity With Curcumin by Binding at Different Sites of Tubulin,” Biochimie 95, no. 6 (2013): 1297–1309.
R. Luo, D. Fang, P. Chu, H. Wu, Z. Zhang, and Z. Tang, “Multiple Molecular Targets in Breast Cancer Therapy by Betulinic Acid,” Biomedicine and Pharmacotherapy 84 (2016): 1321–1330.
J. K. Srivastava and S. Gupta, “Antiproliferative and Apoptotic Effects of Chamomile Extract in Various Human Cancer Cells,” Journal of Agricultural and Food Chemistry 55, no. 23 (2007): 9470–9478.
A. Aribi, S. Gery, D. H. Lee, et al., “The Triterpenoid Cucurbitacin B Augments the Antiproliferative Activity of Chemotherapy in Human Breast Cancer,” International Journal of Cancer 132, no. 12 (2013): 2730–2737.
X. Ying, A. Huang, Y. Xing, L. Lan, Z. Yi, and P. He, “Lycorine Inhibits Breast Cancer Growth and Metastasis via Inducing Apoptosis and Blocking Src/FAK‐Involved Pathway,” Science China Life Sciences 60 (2017): 417–428.
M. Sun, Y. Ye, L. Xiao, X. Duan, Y. Zhang, and H. Zhang, “Anticancer Effects of Ginsenoside Rg3,” International Journal of Molecular Medicine 39, no. 3 (2017): 507–518.
S. E. Nigjeh, S. K. Yeap, N. Nordin, B. Kamalideghan, H. Ky, and R. Rosli, “Citral Induced Apoptosis in MDA‐MB‐231 Spheroid Cells,” BMC Complementary and Alternative Medicine 18 (2018): 1–10.
A. Falodun, N. Engel, U. Kragl, B. Nebe, and P. Langer, “Novel Anticancer Alkene Lactone From Persea americana,” Pharmaceutical Biology 51, no. 6 (2013): 700–706.
J. Du, J. Li, D. Song, et al., “Matrine Exerts Anti‐Breast Cancer Activity by Mediating Apoptosis and Protective Autophagy via the AKT/mTOR Pathway in MCF‐7 Cells,” Molecular Medicine Reports 22, no. 5 (2020): 3659–3666.
M. S. Lim, S. Y. Choung, and K. W. Jeong, “Germacrone Inhibits Estrogen Receptor α‐Mediated Transcription in MCF‐7 Breast Cancer Cells,” Phytotherapy Research 30, no. 12 (2016): 2036–2043.
F. Deng, J. J. Lu, H. Y. Liu, L. P. Lin, J. Ding, and J. S. Zhang, “Synthesis and Antitumor Activity of Novel Salvicine Analogues,” Chinese Chemical Letters 22, no. 1 (2011): 25–28.
E. O. Quisbert‐Valenzuela and G. M. Calaf, “Apoptotic Effect of Noscapine in Breast Cancer Cell Lines,” International Journal of Oncology 48, no. 6 (2016): 2666–2674.
S. Gao, X. Li, X. Ding, W. Qi, and Q. Yang, “Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells,” Cellular Physiology and Biochemistry 41, no. 4 (2017): 1633–1648.
R. Yin, T. Li, J. X. Tian, P. Xi, and R. H. Liu, “Ursolic Acid, a Potential Anticancer Compound for Breast Cancer Therapy,” Critical Reviews in Food Science and Nutrition 58, no. 4 (2018): 568–574.
J. Choi, X. Jiang, J. B. Jeong, and S.‐H. Lee, “Anticancer Activity of Protocatechualdehyde in Human Breast Cancer Cells,” Journal of Medicinal Food 17, no. 8 (2014): 842–848.
S. Dhanalakshmi, C. Agarwal, R. P. Singh, and R. Agarwal, “Silibinin Up‐Regulates DNA‐Protein Kinase‐Dependent p53 Activation to Enhance UVB‐Induced Apoptosis in Mouse Epithelial JB6 Cells,” Journal of Biological Chemistry 280, no. 21 (2005): 20375–20383.
S. Shrivastava, P. Kulkarni, D. Thummuri, et al., “Piperlongumine, an Alkaloid Causes Inhibition of PI3 K/Akt/mTOR Signaling Axis to Induce Caspase‐Dependent Apoptosis in Human Triple‐Negative Breast Cancer Cells,” Apoptosis 19 (2014): 1148–1164.
S. S. Messeha, N. O. Zarmouh, P. Mendonca, H. Alwagdani, C. Cotton, and K. F. Soliman, “Effects of Gossypol on Apoptosis‐Related Gene Expression in Racially Distinct Triple‐Negative Breast Cancer Cells,” Oncology Reports 42, no. 2 (2019): 467–478.
K. Ramasamy and R. Agarwal, “Multitargeted Therapy of Cancer by Silymarin,” Cancer Letters 269, no. 2 (2008): 352–362.
R. Wakimoto, M. Ono, M. Takeshima, T. Higuchi, and S. Nakano, “Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells,” Anticancer Research 37, no. 11 (2017): 6153–6159.
Y. Shukla and M. Singh, “Cancer Preventive Properties of Ginger: A Brief Review,” Food and Chemical Toxicology 45, no. 5 (2007): 683–690.
Y. Sun, X. Lin, and H. Chang, “Proliferation Inhibition and Apoptosis of Breast Cancer MCF‐7 Cells Under the Influence of Colchicine,” Journal of BUON 3 (2016): 570–575.
Q. Wu, K. Zheng, X. Huang, L. Li, and W. Mei, “Tanshinone‐IIA‐Based Analogues of Imidazole Alkaloid act as Potent Inhibitors to Block Breast Cancer Invasion and Metastasis In Vivo,” Journal of Medicinal Chemistry 61, no. 23 (2018): 10488–10501.
Y. Zhu, R. F. Warin, D. N. Soroka, H. Chen, and S. Sang, “Metabolites of Ginger Component [6]‐Shogaol Remain Bioactive in Cancer Cells and Have low Toxicity in Normal Cells: Chemical Synthesis and Biological Evaluation,” PLoS One 8, no. 1 (2013): e54677.
V. Hanušová, K. Caltová, H. Svobodová, et al., “The Effects of β‐Caryophyllene Oxide and Trans‐Nerolidol on the Efficacy of Doxorubicin in Breast Cancer Cells and Breast Tumor‐Bearing Mice,” Biomedicine and Pharmacotherapy 95 (2017): 828–836.
L. Zan, Q. Chen, L. Zhang, and X. Li, “Epigallocatechin Gallate (EGCG) Suppresses Growth and Tumorigenicity in Breast Cancer Cells by Downregulation of miR‐25,” Bioengineered 10, no. 1 (2019): 374–382.
S. Garvin, K. Öllinger, and C. Dabrosin, “Resveratrol Induces Apoptosis and Inhibits Angiogenesis in Human Breast Cancer Xenografts In Vivo,” Cancer Letters 231, no. 1 (2006): 113–122.
G. Ş. Karatoprak, E. Küpeli Akkol, Y. Genç, H. Bardakcı, Ç. Yücel, and E. Sobarzo‐Sánchez, “Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications,” Molecules 25, no. 11 (2020): 2560.
Y. Park, S. H. Woo, S. K. Seo, et al., “Ginkgetin Induces Cell Death in Breast Cancer Cells via Downregulation of the Estrogen Receptor,” Oncology Letters 14, no. 4 (2017): 5027–5033.
M. Tripathi, P. Reddy, and D. Rawat, “Noscapine and Its Analogues as Anti‐Cancer Agents,” Chem Biol Interface 4 (2014): 1–22.
L. Chen, H.‐J. Wang, W. Xie, Y. Yao, Y.‐S. Zhang, and H. Wang, “Cryptotanshinone Inhibits Lung Tumorigenesis and Induces Apoptosis in Cancer Cells In Vitro and In Vivo,” Molecular Medicine Reports 9, no. 6 (2014): 2447–2452.